Oesophageal Cancer

How common is oesophageal cancer?

The incidence of oesophageal cancer has been steadily rising over the last 10 years. It usually affects the 50-75 age group and is more common in males than females. In the UK, the majority of oesophageal cancers are adenocarcinomas, which arise around the junction between the oesophagus and stomach. The other main type is squamous cell carcinoma, which usually occurs higher up in the oesophagus.

Who does it effect?

The rise in incidence of oesophageal adenocarcinoma, is thought to be related to gastro-oesophageal reflux disease and obesity. Squamous cell cancers are caused by smoking, alcohol and certain dietary factors.

How is it detected?

The majority of patients will present with difficulty in swallowing. Any patients with swallowing difficulties or new reflux symptoms should be urgently investigated.

Some cancers are detected whilst patients are under surveillance for a condition known as Barrett’s Oesophagus. This is a change in the lining of the oesophagus due to the high exposure of the lower oesophagus to acid reflux. Patients with this condition are more likely to develop oesophageal cancer and are usually regularly checked by endoscopy.

How is the diagnosis made?

The first investigation for swallowing difficulties is an endoscopy. Biopsies are taken and sent to the laboratory for analysis. It usually takes 3-5 days to get a result. Once the diagnosis has been made a series of investigations are performed to gain an understanding of the extent of the cancer (cancer staging).

How is the oesophageal cancer treated?

The staging tests outlined above enable us to understand how far the cancer has spread. If the cancer remains confined to the oesophagus, then a curative approach is used. Cancer, which has spread away from the oesophagus to other organs, may not be curable and will require chemotherapy to attempt to gain control of the disease. If the cancer is very early, it can be treated by endoscopy. The majority of curable cancers will require a combination of chemotherapy and surgery to obtain the best results. In certain situations, radiotherapy will also be considered for further treatment. The LSG works with leading oncologists and gastro-enterologists to provide these services.